WILSON TROY EDWARD 4
4 · Kura Oncology, Inc. · Filed Aug 14, 2025
Insider Transaction Report
Form 4
WILSON TROY EDWARD
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2025-08-12$5.85/sh+36,506$213,578→ 37,474 total - Purchase
Common Stock
2025-08-13$6.64/sh+13,494$89,623→ 50,968 total
Holdings
- 279,194(indirect: By Trust)
Common Stock
- 300,000(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $5.56 to $5.995. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]Includes 409 shares acquired on May 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F3]This transaction was executed in multiple trades at prices ranging from $6.485 to $6.735. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.